Cite
APA Citation
Mesa, R., Oh, S. T., Gerds, A. T., Gupta, V., Catalano, J., Cervantes, F., Devos, T., Hus, M., Kiladjian, J., Lech-Maranda, E., McLornan, D., Palmer, J., Platzbecker, U., Treliński, J., Shimoda, K., Donahue, R., D'Hollander, K., Kowalski, M., & Verstovsek, S. (2022). momelotinib reduces transfusion requirements in patients with myelofibrosis. Leukemia & lymphoma, 63(7), 1718–1722. http://access.bl.uk/ark:/81055/vdc_100159165391.0x00002e